newsfilter
← Latest News
GlobeNewswire·

Windtree Announces Publication of Positive Istaroxime Phase 2b Study Trial Design

WARRINGTON, Pa., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. ("Windtree" or the "Company") (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for